» Articles » PMID: 30149001

Altered Nuclear Envelope Structure and Proteasome Function of Micronuclei

Overview
Journal Exp Cell Res
Specialty Cell Biology
Date 2018 Aug 28
PMID 30149001
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Micronuclei are extra-nuclear bodies containing whole chromosomes that were not incorporated into the nucleus after cell division or damaged chromosome fragments. Even though the link between micronuclei and DNA damage is described for a long time, little is known about the functional organization of micronuclei and their contribution to tumorigenesis. We showed fusions between micronuclear membranes and lysosomes by electron microscopy and linked lysosome function to DNA damage levels in micronuclei. In addition, micronuclei drastically differ from primary nuclei in nuclear envelope composition, with a significant increase in the relative amount of nuclear envelope proteins LBR and emerin and a decrease in nuclear pore proteins. Strikingly, micronuclei lack active proteasomes, as the processing subunits and other factors of the ubiquitin proteasome system. Moreover, micronuclear chromatin shows a higher degree of compaction as compared to primary nuclei. The specific aberrations identified in micronuclei and the potential functional consequences of these defects may contribute to the role of micronuclei in catastrophic genomic rearrangements.

Citing Articles

A TRilogy of ATR's Non-Canonical Roles Throughout the Cell Cycle and Its Relation to Cancer.

Joo Y, Ramirez C, Kabeche L Cancers (Basel). 2024; 16(20).

PMID: 39456630 PMC: 11506335. DOI: 10.3390/cancers16203536.


Emerin mislocalization during chromatin bridge resolution can drive prostate cancer cell invasiveness in a collagen-rich microenvironment.

Popeda M, Kowalski K, Wenta T, Beznoussenko G, Rychlowski M, Mironov A Exp Mol Med. 2024; 56(9):2016-2032.

PMID: 39218980 PMC: 11446916. DOI: 10.1038/s12276-024-01308-w.


Fate of micronuclei and micronucleated cells after treatment of HeLa cells with different genotoxic agents.

Reimann H, Stopper H, Hintzsche H Arch Toxicol. 2022; 97(3):875-889.

PMID: 36564592 PMC: 9968706. DOI: 10.1007/s00204-022-03433-9.


Genome integrity and inflammation in the nervous system.

Aditi , McKinnon P DNA Repair (Amst). 2022; 119:103406.

PMID: 36148701 PMC: 9844216. DOI: 10.1016/j.dnarep.2022.103406.


CRISPRthripsis: The Risk of CRISPR/Cas9-induced Chromothripsis in Gene Therapy.

Amendola M, Brusson M, Miccio A Stem Cells Transl Med. 2022; 11(10):1003-1009.

PMID: 36048170 PMC: 9585945. DOI: 10.1093/stcltm/szac064.